COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19

S Shibata, K Kobayashi, M Tanaka, K Asayama… - Hypertension …, 2023 - nature.com
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Hypertension management before and under the COVID-19 pandemic: lessons and future directions

Y Nozato, K Yamamoto, H Rakugi - Hypertension Research, 2023 - nature.com
Hypertension is a significant risk factor for cardiovascular diseases. The prevalence of
hypertension and its complications is increasing yearly, yet it remains inadequately …

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of …

FJ Charchar, PR Prestes, C Mills, SM Ching… - Journal of …, 2024 - journals.lww.com
Hypertension, defined as persistently elevated systolic blood pressure (SBP)> 140 mmHg
and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice

K Kario, N Harada, A Okura - Hypertension Research, 2022 - nature.com
In 2021, the open-label randomized HERB-Digital Hypertension 1 (HERB-DH1) trial showed
for the first time that hypertension digital therapeutics (a hypertension treatment app) …

Digital hypertension 2023: concept, hypothesis, and new technology

K Kario, S Hoshide, M Mogi - Hypertension Research, 2022 - nature.com
We will launch the special issue “Digital Hypertension 2023” in collaboration with “Digital
Health”, a new journal from Springer Nature. Recent remarkable developments in …

Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended

K Kario, N Tomitani, T Fujiwara, Y Okawara… - Hypertension …, 2023 - nature.com
While home blood pressure (BP) measurement is recommended for hypertension
management, the clinical implications of peak home BP values have not been well studied …

Telemedicine and digital medicine in the clinical management of hypertension and hypertension-related cardiovascular diseases: a position paper of the Italian …

P Minuz, FL Albini, E Imbalzano, R Izzo, S Masi… - High Blood Pressure & …, 2023 - Springer
High blood pressure is the leading cause of death and disability globally and an important
treatable risk factor for cardiovascular, cerebrovascular and chronic kidney diseases. Digital …

Lifetime home BP-centered approach is the core from onset to aggravation of hypertension

K Kario, S Hoshide, M Mogi - Hypertension Research, 2023 - nature.com
Hypertension is the lifetime risk for organ damage and cardiovascular disease. The risk of
high blood pressure (BP) is initiated before the diagnosis of hypertension. From healthy …